✦ LIBER ✦

Prognostic Value of Platelet Count in Diffuse Large B-Cell Lymphoma

✍ Scribed by Ling-Ping Chen; Shyh-Jer Lin; Ming-Sun Yu

Book ID: 119219005
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 303 KB
Volume: 12
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.215

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic Value of Bcl 10 Rearrangement

Prognostic Value of Bcl 10 Rearrangement in Diffuse Large B-cell Lymphoma

✍ Kawasaki, C.; Ohshima, K.; Muta, H.; Muta, K.; Deyev, V.; Podack, E.R.; Kikuchi, 📂 Article 📅 2002 🏛 Informa plc 🌐 English ⚖ 277 KB

Absolute lymphocyte count is a prognosti

Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma

✍ M. Christina Cox; Italo Nofroni; Giacinto Laverde; Antonella Ferrari; Rachele Am 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Prognostic models for diffuse large b-ce

Prognostic models for diffuse large b-cell lymphoma

✍ Annarita Conconi; Emanuele Zucca; Enrico Roggero; Francesco Bertoni; Augusto Ber 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Prognosis of DLCL patients is variable and associated with well-de®ned risk factors. In the past decade several pretreatment variables have been incorporated into prognostic models to predict the death risk of individual patients. The International Prognostic Index (IPI), developed in an internation

Molecular prognostic factors in diffuse

Molecular prognostic factors in diffuse large B-cell lymphoma

✍ Daniel Morgensztern; Izidore S. Lossos 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 375 KB

Prognostic value of GST-π expression in

Prognostic value of GST-π expression in diffuse large B-cell lymphomas

✍ Ribrag, V; Koscielny, S; Carpiuc, I; Cebotaru, C; Vande Walle, H; Talbot, M; Fen 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 320 KB

Biomarkers of potential prognostic signi

Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma

✍ Grace Wu; Armand Keating 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract Diffuse large B‐cell lymphoma (DLBCL) is a biologically heterogeneous disease for which the current approach to treatment is only successful for 50% of patients. The prognostic value of various clinical and biological factors in predicting treatment outcome is discussed in this paper. A